Theranos Settles $96M Investor Damage, Share Swap Suits
Biotech venture Theranos Inc. has agreed to an undisclosed settlement with two hedge funds that claimed they were misled about the reliability and performance of the company's remote blood testing labs...To view the full article, register now.
Already a subscriber? Click here to view full article